ArticleThe Lancet. Neurology2018
Hypercholinergic activity in LRRK2 Parkinson's disease.
Nicolaas I Bohnen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Lancet. Neurology2018
Nicolaas I Bohnen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.